Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 173, Issue 5, Pages 693-702
Publisher
Bioscientifica
Online
2015-10-02
DOI
10.1530/eje-15-0500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Growth Hormone, Insulin-Like Growth Factor-1, and the Kidney: Pathophysiological and Clinical Implications
- (2014) Peter Kamenický et al. ENDOCRINE REVIEWS
- Surgical Interventions and Medical Treatments in Treatment-Naïve Patients With Acromegaly: Systematic Review and Meta-Analysis
- (2014) Abd Moain Abu Dabrh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of Surgical Treatment of Acromegaly: Effects on Ghrelin, Weight, Adiposity, and Markers of CV Risk
- (2014) Carlos Reyes-Vidal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Successful Treatment of Acromegaly on Overnight Heart Rate Variability and Sleep Apnea
- (2014) Denis Chemla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- No Evidence of Ectopic Lipid Accumulation in the Pathophysiology of the Acromegalic Cardiomyopathy
- (2014) Yvonne Winhofer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
- (2014) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effects of medical therapies for acromegaly on glucose metabolism
- (2013) C Urbani et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias
- (2012) Renata S Auriemma et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
- (2012) Luigi Maione et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Body Fluid Expansion in Acromegaly Is Related to Enhanced Epithelial Sodium Channel (ENaC) Activity
- (2011) Peter Kamenicky et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
- (2011) John A. Jane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Improvement of cardiac parameters in patients with acromegaly treated with medical therapies
- (2011) Annamaria Colao Pituitary
- Endocrine Aspects of Obstructive Sleep Apnea
- (2010) Pierre Attal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control
- (2010) Christian Berg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
- (2009) Peter J. Trainer et al. CLINICAL ENDOCRINOLOGY
- Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
- (2009) Mónica Marazuela et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly
- (2009) Peter Kamenicky et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly
- (2009) C Berg et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rapidly Reversible Myocardial Edema in Patients with Acromegaly: Assessment with Ultrafast T2 Mapping in a Single-Breath-Hold MRI Sequence
- (2008) Hervé Gouya et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Epithelial Sodium Channel Is a Key Mediator of Growth Hormone-Induced Sodium Retention in Acromegaly
- (2008) Peter Kamenicky et al. ENDOCRINOLOGY
- Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging.
- (2008) Flávia R B van Haute et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study.
- (2008) U Plöckinger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease
- (2008) Maria Vittoria Davi' et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Alterations in body composition in acromegaly
- (2008) Laurence Katznelson Pituitary
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started